 Home > Medical News > Latest Medical News > FCN-342 Tablets, a subsidiary of Fosun Pharma Holding Group, Obtained Drug Clinical Trial Approval

FCN-342 Tablets, a subsidiary of Fosun Pharma Holding Group, Obtained Drug Clinical Trial Approval

 Last Update: 2021-12-09
 Source: Internet
 Author: User

Tags

met inhibitor

renin inhibitor drugs

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On November 8, Fosun Pharma issued an announcement stating that its controlling subsidiary, Fosun Pharma, had received approval from the National Medical Products Administration for the development of FCN-342 tablets for the treatment of gout

The new drug is a URAT1 inhibitor independently developed by the company and is intended to be mainly used for the treatment of gout and hyperuricemia

As of the date of this announcement, the same-target drugs that have been marketed in China are benzbromarone, mainly including Lijialixian® from Sano Arzneimittelfabrik GmbH, Ertongshu® from Yichang East Sunshine Yangtze River Pharmaceutical Co.

As of September 2021, the Group has invested approximately RMB 18 million in R&D for this new drug at this stage (unaudited)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.